Professionals 339 results
Capabilities 85 results
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Industry
Practice Area
Environmental Litigation & Enforcement
Experience 203 results
Experience
|February 18, 2026
RF Acquisition Corp III Announces Closing of $100 Million Initial Public Offering
Experience
|February 2, 2026
Experience
|January 27, 2026
Virtuix Holdings Inc. Direct Listing on the Nasdaq Global Market
Insights & News 3,703 results
Client Alert
|March 9, 2026
|3 Min Read
On January 27, 2026, the U.S. Department of Health and Human Services Office of Inspector General (the OIG) issued a Special Advisory Bulletin (the Bulletin) addressing the application of the federal anti-kickback statute (the AKS) to direct-to-consumer (DTC) prescription drug sales.
The Bulletin, the OIG’s first Special Advisory Bulletin since September 2014, was issued in response to the proliferation of DTC programs. The Bulletin, which sets forth the framework under which a manufacturer’s DTC program presents a low risk of violating the AKS, is viewed by the growing DTC industry as favorable guidance. DTC programs offering modern weight-loss medications, such as GLP-1 drugs, are becoming increasingly popular, and the Bulletin provides a helpful framework to support the viability of these programs.
Non-Fungible Insights: Blockchain Decrypted
|March 6, 2026
|7 Min Read
The close of 2025 highlighted the continuing momentum for the digital asset industry, with regulatory developments accelerating rather than slowing.
In the Media
|March 6, 2026
|1 Min Read
Amelia Garza-Mattia Discusses VPPA Consumer Definition Case with Law360
Other Results 116 results
Site Content
Site Content


